,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-08-13 07:17:00,Investors looking for long-term growth sometimes seek momentum stocks in an attempt to find significant gains amid all the market madness.,0.46930694580078125,0.04826173186302185,0.4824312925338745,neutral,0.4210452139377594
1,2018-08-13 07:17:00,"As such, I looked for stocks with strong momentum on a 12-month basis.",0.5043122172355652,0.014441024512052536,0.4812467098236084,positive,0.48987120389938354
2,2018-08-13 07:17:00,"As you will see below, these momentum stocks have delivered whopping gains over the last year.",0.9203336834907532,0.016733450815081596,0.0629328116774559,positive,0.9036002159118652
3,2018-08-13 07:17:00,"And on a three-month basis, they aren't doing too bad either.",0.24336238205432892,0.11394131183624268,0.6426963210105896,neutral,0.12942107021808624
4,2018-08-13 07:17:00,"But even better, I used TipRanks to combine this momentum search with a search for ""strong buy"" stocks.",0.15354563295841217,0.011119253933429718,0.8353350758552551,neutral,0.14242637157440186
5,2018-08-13 07:17:00,These are stocks with the most bullish ratings from the best-performing analysts on Wall Street.,0.37850940227508545,0.045930199325084686,0.575560450553894,neutral,0.33257919549942017
6,2018-08-13 07:17:00,"Investors can rest easy in their search, as these are the best momentum stocks with big Street support from the top experts.",0.42596763372421265,0.016971692442893982,0.557060718536377,neutral,0.40899592638015747
7,2018-08-13 07:17:00,Finding stocks that have strong gains and strong Street support can help avoid the tipping point where momentum stocks just become too expensive and fall back regardless of fundamental strength.,0.3689965605735779,0.056523848325014114,0.5744795799255371,neutral,0.31247270107269287
8,2018-08-13 07:17:00,So what will the future hold for these seven strong buy stock picks?,0.07481164485216141,0.02525070309638977,0.8999376893043518,neutral,0.04956094175577164
9,2018-08-13 07:17:00,"Let's take a closer look:

Amazon (NASDAQ: AMZN ) is killing it right now.",0.06574565172195435,0.48311084508895874,0.4511435031890869,negative,-0.4173651933670044
10,2018-08-13 07:17:00,"And the company is setting itself up for significant continuous growth, as top D.A.",0.8972724080085754,0.014029010199010372,0.08869859576225281,positive,0.8832433819770813
11,2018-08-13 07:17:00,Davidson analyst Tom Forte ( Profile & Recommendations ) has identified two additional $1 trillion markets for Amazon: Travel and gas.,0.14149513840675354,0.005853850394487381,0.852651059627533,neutral,0.13564129173755646
12,2018-08-13 07:17:00,"""Based on our estimates, Amazon is currently pursuing 8 of 10 market opportunities that exceed $1T, globally.",0.39564570784568787,0.008261097595095634,0.5960931777954102,neutral,0.3873846232891083
13,2018-08-13 07:17:00,"We see an opportunity for it to exploit the remaining two - gas (stations) and travel"", Forte explained.",0.7679370641708374,0.010580858215689659,0.22148200869560242,positive,0.7573562264442444
14,2018-08-13 07:17:00,"Such an expansion would make sense because the ""company has a history of solving complex logistical problems.",0.6046457290649414,0.02003704383969307,0.37531718611717224,positive,0.5846086740493774
15,2018-08-13 07:17:00,"Financially, it seeks opportunities that can generate significant free cash flow.""",0.811417281627655,0.01127716712653637,0.17730556428432465,positive,0.8001401424407959
16,2018-08-13 07:17:00,"In terms of travel, ""Amazon could sell consumers not only the airline tickets and hotel accommodations but also everything they need for their trip"", the analyst added.",0.1905117779970169,0.006355429999530315,0.8031327724456787,neutral,0.18415634334087372
17,2018-08-13 07:17:00,"He reiterated his Buy rating on Aug. 7 with a bullish $2,200 price target (18% upside potential).",0.7777059674263,0.021049316972494125,0.20124471187591553,positive,0.7566566467285156
18,2018-08-13 07:17:00,"With its savvy acquisition of PillPack, Amazon is already a player in the pharmacy market.",0.9067229628562927,0.014751121401786804,0.07852596789598465,positive,0.8919718265533447
19,2018-08-13 07:17:00,"Other categories where Amazon has a presence include apparel, grocery, consumer internet of things and B2B e-commerce.",0.01798541471362114,0.006383736617863178,0.9756308794021606,neutral,0.011601678095757961
20,2018-08-13 07:17:00,Overall this strong buy stock scores 38 buy ratings vs two hold ratings in the last three months.,0.8899514079093933,0.037598516792058945,0.07245013117790222,positive,0.8523529171943665
21,2018-08-13 07:17:00,"This is with a $2,103 average analyst price target.",0.04204725846648216,0.010478461161255836,0.9474743008613586,neutral,0.03156879544258118
22,2018-08-13 07:17:00,See what other Top Analysts are saying about AMZN .,0.016998115926980972,0.009446662850677967,0.9735551476478577,neutral,0.007551453076303005
23,2018-08-13 07:17:00,"Headquartered in San Diego, California, Illumina (NASDAQ: ILMN ) is a life sciences company offering instruments, consumables and services for genetic analysis.",0.047376714646816254,0.0042594801634550095,0.9483638405799866,neutral,0.043117232620716095
24,2018-08-13 07:17:00,Shares surged following outstanding Q2 results with a broad-based beat.,0.937125027179718,0.02256896160542965,0.040306128561496735,positive,0.914556086063385
25,2018-08-13 07:17:00,Plus the company boosted its 2018 sales guide to 20% year-over-year growth.,0.9502935409545898,0.020309079438447952,0.02939740940928459,positive,0.929984450340271
26,2018-08-13 07:17:00,"According to Canaccord Genuity analyst Mark Massaro ( Profile & Recommendations ), the major beat and raised guidance confirms it is a must-own stock in 2018.",0.6393988132476807,0.036139074712991714,0.3244621455669403,positive,0.6032597422599792
27,2018-08-13 07:17:00,He now sees the stock streaming toward over $4 billion in revenues by 2020.,0.8330965042114258,0.013087299652397633,0.1538160890340805,positive,0.8200092315673828
28,2018-08-13 07:17:00,"With this in mind, Massaro ramped up his price target $10 to $340.",0.7331037521362305,0.017087887972593307,0.24980829656124115,positive,0.7160158753395081
29,2018-08-13 07:17:00,"However, Merrill Lynch's Derik De Bruin is way ahead of him.",0.21944878995418549,0.045242492109537125,0.7353087663650513,neutral,0.17420630156993866
30,2018-08-13 07:17:00,He has a Street-high-price-target of $370.,0.07681726664304733,0.03381150960922241,0.8893712162971497,neutral,0.04300575703382492
31,2018-08-13 07:17:00,"According to De Bruin, Illumina is firing on all cylinders, with Q2 thrashing consensus.",0.5457857251167297,0.17672598361968994,0.2774882912635803,positive,0.3690597414970398
32,2018-08-13 07:17:00,He sees at least +21% sales growth in '18.,0.9350914359092712,0.015081171877682209,0.04982733726501465,positive,0.9200102686882019
33,2018-08-13 07:17:00,"And bottom line for De Bruin is that he is ""positive on Illumina's prospects due to wide adoption of the company's innovative genetic analysis tools, strong competitive position, and impressive forward-looking product and market strategy.""",0.9166339039802551,0.014479297213256359,0.06888678669929504,positive,0.9021546244621277
34,2018-08-13 07:17:00,"• 7 3D-Printing Stocks to Buy As the Space Keeps Growing

Illumina has scored nine recent buy ratings vs just one hold rating.",0.8072125911712646,0.02596432715654373,0.16682305932044983,positive,0.7812482714653015
35,2018-08-13 07:17:00,Its average price target stands at $340.,0.03393562138080597,0.009179655462503433,0.9568846821784973,neutral,0.024755965918302536
36,2018-08-13 07:17:00,See what other Top Analysts are saying about ILMN .,0.015973905101418495,0.00969298742711544,0.9743331670761108,neutral,0.006280917674303055
37,2018-08-13 07:17:00,Align Technology (NASDAQ: ALGN ) is the company behind a straight-teeth revolution.,0.30870285630226135,0.012346625328063965,0.6789504885673523,neutral,0.2963562309741974
38,2018-08-13 07:17:00,It is the creator of the popular transparent teeth aligners (known as Invisalign).,0.0807001069188118,0.006570099852979183,0.9127297401428223,neutral,0.07413000613451004
39,2018-08-13 07:17:00,"The stock has put on a stunning recent performance, more than doubling in the last year.",0.9398588538169861,0.01985105499625206,0.04029016196727753,positive,0.9200078248977661
40,2018-08-13 07:17:00,"Following stellar Q2 results, Piper Jaffray analyst Matt O'Brien ( Profile & Recommendations ) raised his price target for Align to $440.",0.7555294632911682,0.014064054004848003,0.23040643334388733,positive,0.7414653897285461
41,2018-08-13 07:17:00,"He notes that results were strong across the board and ""easily topped"" his estimates on both the top- and bottom-lines.",0.9497631192207336,0.019331417977809906,0.030905427411198616,positive,0.9304317235946655
42,2018-08-13 07:17:00,"Most interestingly, sales of its iTero intraoral scanners drove most of the upside, O'Brien told investors.",0.14070916175842285,0.021589934825897217,0.8377009034156799,neutral,0.11911922693252563
43,2018-08-13 07:17:00,This bodes well for Invisalign sales.,0.8258376717567444,0.014175309799611568,0.15998712182044983,positive,0.8116623759269714
44,2018-08-13 07:17:00,"As far as he's aware, clinicians only buy scanners if they intend to use a lot of aligners in the future, a ""very positive sign for the company's outlook.""",0.6724259853363037,0.020438607782125473,0.3071354329586029,positive,0.6519873738288879
45,2018-08-13 07:17:00,Even disappointing Q3 guidance doesn't distract from the overall bullish outlook says O'Brien.,0.08150708675384521,0.8468338847160339,0.07165897637605667,negative,-0.7653267979621887
46,2018-08-13 07:17:00,"He believes that ""this is part of the typical conservative playbook management employs.""",0.06392998993396759,0.0074075437150895596,0.9286624789237976,neutral,0.05652244761586189
47,2018-08-13 07:17:00,"As a result, the analyst recommends starting or increasing ALGN positions.",0.8748382329940796,0.01579105295240879,0.10937071591615677,positive,0.8590471744537354
48,2018-08-13 07:17:00,"Overall, nine analysts have rated ALGN a buy in the last three months.",0.7246429324150085,0.01951500214636326,0.25584208965301514,positive,0.7051279544830322
49,2018-08-13 07:17:00,This is versus two hold ratings.,0.3527676463127136,0.08750548958778381,0.5597268342971802,neutral,0.2652621567249298
50,2018-08-13 07:17:00,"From all these analysts, the average price target stands at $400.",0.033836379647254944,0.01623750850558281,0.9499261379241943,neutral,0.017598871141672134
51,2018-08-13 07:17:00,See what other Top Analysts are saying about ALGN .,0.016461579129099846,0.008875737898051739,0.974662721157074,neutral,0.007585841231048107
52,2018-08-13 07:17:00,Salesforce (NYSE: CRM ) is getting stronger.,0.9368601441383362,0.017802000045776367,0.04533790051937103,positive,0.9190581440925598
53,2018-08-13 07:17:00,CRM is a proven market share taker that ticks all the boxes.,0.6590014696121216,0.015844538807868958,0.3251539468765259,positive,0.6431569457054138
54,2018-08-13 07:17:00,"Think disruptive products, a visionary CEO and robust business fundamentals.",0.7153522372245789,0.014071921817958355,0.27057579159736633,positive,0.7012802958488464
55,2018-08-13 07:17:00,Oppenheimer's Brian Schwartz ( Profile & Recommendations ) is one of the Top 10 analysts ranked by TipRanks.,0.14353948831558228,0.013640486635267735,0.8428200483322144,neutral,0.12989899516105652
56,2018-08-13 07:17:00,And he is growing increasingly bullish on the stock.,0.1734040230512619,0.13720235228538513,0.6893936395645142,neutral,0.03620167076587677
57,2018-08-13 07:17:00,The analyst has just carried out an encouraging survey of CRM customers.,0.8557843565940857,0.015859514474868774,0.12835611402988434,positive,0.8399248123168945
58,2018-08-13 07:17:00,"The results revealed an uptick in customer engagement spending, and an upcoming investment cycle.",0.9151317477226257,0.014153723604977131,0.07071451097726822,positive,0.9009780287742615
59,2018-08-13 07:17:00,"Customers want to operate on a single CRM platform, but many are still using inefficient technologies that will soon need upgrading.",0.0953817367553711,0.053262725472450256,0.8513555526733398,neutral,0.04211901128292084
60,2018-08-13 07:17:00,"""We see good upside potential to the financial targets since the installed base has a desire for a modern, next-generation customer engagement system from a leading platform supplier like salesforce.com"", writes Schwartz.",0.9032691121101379,0.012648755684494972,0.08408210426568985,positive,0.8906203508377075
61,2018-08-13 07:17:00,He raised his price target to $160 from $152.,0.7799249291419983,0.022619690746068954,0.19745536148548126,positive,0.7573052644729614
62,2018-08-13 07:17:00,"Ultimately, this analyst concludes: ""We consider CRM one of the healthiest long-term growth stories in our SaaS/applications software universe.""",0.8995576500892639,0.015291916206479073,0.08515049517154694,positive,0.8842657208442688
63,2018-08-13 07:17:00,Clearly other analysts feel the same.,0.10351559519767761,0.021633338183164597,0.8748511075973511,neutral,0.08188225328922272
64,2018-08-13 07:17:00,"CRM has received 26 buy ratings in the last three months, with two analysts staying sidelined.",0.1404769867658615,0.626275360584259,0.23324763774871826,negative,-0.48579835891723633
65,2018-08-13 07:17:00,"Meanwhile, the average analyst price target works out at $152.89.",0.11120248585939407,0.06062738597393036,0.828170120716095,neutral,0.050575099885463715
66,2018-08-13 07:17:00,See what other Top Analysts are saying about CRM .,0.014843897894024849,0.010595184750854969,0.9745609164237976,neutral,0.00424871314316988
67,2018-08-13 07:17:00,Master of its domain.,0.056838978081941605,0.02366672456264496,0.9194942712783813,neutral,0.033172253519296646
68,2018-08-13 07:17:00,This is how Cantor Fitzgerald's Joseph Foresi ( Profile & Recommendations ) describes Mastercard (NYSE: MA ) stock.,0.014338506385684013,0.009915138594806194,0.9757462739944458,neutral,0.004423367790877819
69,2018-08-13 07:17:00,The company has just reported another round of impressive earnings results.,0.9487718343734741,0.01783973164856434,0.03338839113712311,positive,0.9309321045875549
70,2018-08-13 07:17:00,"Like Brian Schwartz, Foresi stands out as one of the Top 10 analysts ranked by TipRanks.",0.35151320695877075,0.018654581159353256,0.6298322081565857,neutral,0.3328586220741272
71,2018-08-13 07:17:00,"He has now reiterated his MA buy rating, while shooting his price target to $237 from $213.",0.8227037191390991,0.025054113939404488,0.15224212408065796,positive,0.797649621963501
72,2018-08-13 07:17:00,"""We value Mastercard at a premium to the group due to its strong growth"", comments the analyst.",0.7696659564971924,0.020754698663949966,0.20957933366298676,positive,0.7489112615585327
73,2018-08-13 07:17:00,"Results for Q2 2018 smashed street expectations, with solid growth across all segments.",0.9461425542831421,0.01763835921883583,0.03621897101402283,positive,0.9285041689872742
74,2018-08-13 07:17:00,"Most notably, worldwide GDV growth remained strong in the mid-teens and Purchase Transaction volume growth accelerated to ~20% in the period.",0.9436010718345642,0.014088175259530544,0.04231075569987297,positive,0.9295129179954529
75,2018-08-13 07:17:00,"Indeed, Foresi believes that MA can grow faster than peers.",0.9273068904876709,0.013913290575146675,0.05877985432744026,positive,0.9133936166763306
76,2018-08-13 07:17:00,It also has potential to expand its margins.,0.9466080665588379,0.01581992767751217,0.03757205232977867,positive,0.9307881593704224
77,2018-08-13 07:17:00,"""We remain attracted to Mastercard's card network and strong products and solutions, which should continue to drive solid performance"", he concludes.",0.941027820110321,0.013794601894915104,0.045177657157182693,positive,0.9272332191467285
78,2018-08-13 07:17:00,Seventeen analysts have published recent buy ratings on this strong buy stock.,0.32266947627067566,0.011469453573226929,0.6658610701560974,neutral,0.31120002269744873
79,2018-08-13 07:17:00,"Meanwhile, two analysts published hold ratings.",0.0183656457811594,0.05249469727277756,0.9291396141052246,neutral,-0.034129053354263306
80,2018-08-13 07:17:00,This is with a $229 price target.,0.06137257441878319,0.020737960934638977,0.917889416217804,neutral,0.04063461348414421
81,2018-08-13 07:17:00,See what other Top Analysts are saying about MA .,0.025302080437541008,0.013334190472960472,0.9613637328147888,neutral,0.011967889964580536
82,2018-08-13 07:17:00,Harris Corporation (NYSE: HRS ) is a leading aerospace and defense company with a tech focus.,0.60666823387146,0.010830816812813282,0.3825009763240814,positive,0.595837414264679
83,2018-08-13 07:17:00,"""From ocean to orbit"" is how Harris describes its products.",0.01936713233590126,0.008446285501122475,0.9721865653991699,neutral,0.010920846834778786
84,2018-08-13 07:17:00,They cover everything from tactical radios and night vision technology to undersea systems and Earth observation.,0.024393269792199135,0.005600425880402327,0.9700063467025757,neutral,0.01879284344613552
85,2018-08-13 07:17:00,Credit Suisse analyst Robert Spingarn ( Profile & Recommendations ) raised his price target for Harris to $190 from $175 on Aug. 1.,0.8452900648117065,0.0174581166356802,0.13725179433822632,positive,0.8278319239616394
86,2018-08-13 07:17:00,The move came after the company ramped up its medium-term guidance.,0.8373126983642578,0.01482385490089655,0.14786337316036224,positive,0.8224888443946838
87,2018-08-13 07:17:00,"""Management raised its ""medium term"" sales guidance from 5%+ to ""mid- to high-single digit"" growth, with broad based participation across segments"", notes Spingarn.",0.9425764679908752,0.013220800086855888,0.044202689081430435,positive,0.9293556809425354
88,2018-08-13 07:17:00,Plus earning results proved that the company's tactical radio prospects remain strong.,0.9456937313079834,0.015822669491171837,0.0384836420416832,positive,0.9298710823059082
89,2018-08-13 07:17:00,"Not only does HRS enter F19 with above average sales visibility, but the bid pipeline also remains promising.",0.9339318871498108,0.01486324705183506,0.051204863935709,positive,0.9190686345100403
90,2018-08-13 07:17:00,"Moreover, according to Spingarn, ""despite the Trump Administration's public tension with NATO allies, HRS is seeing more interest in its radios (despite being a U.S. supplier) from allied nations as they increase their military spending"".",0.9342797994613647,0.022331399843096733,0.043388739228248596,positive,0.9119483828544617
91,2018-08-13 07:17:00,"• 7 Best Places for Millennials to Work (That Are Also Great Stocks to Buy)

Harris has received only buy ratings from the Street in the last three months.",0.13816070556640625,0.19604729115962982,0.6657920479774475,neutral,-0.05788658559322357
92,2018-08-13 07:17:00,See what other Top Analysts are saying about HRS .,0.01761230081319809,0.011075085029006004,0.9713125824928284,neutral,0.006537215784192085
93,2018-08-13 07:17:00,Abiomed (NASDAQ: ABMD ) is pioneering a new generation of heart-related medical devices.,0.6148979663848877,0.010699314065277576,0.3744027018547058,positive,0.6041986346244812
94,2018-08-13 07:17:00,"This includes the AbioCor artificial heart and Impella, the world's smallest heart pump.",0.07118755578994751,0.010645278729498386,0.9181671142578125,neutral,0.0605422779917717
95,2018-08-13 07:17:00,"Following its dramatic price rise, you may be worried that the stock is looking too pricey.",0.05188148468732834,0.7345835566520691,0.21353492140769958,negative,-0.6827020645141602
96,2018-08-13 07:17:00,But that would be underestimating Abiomed's massive growth potential.,0.18557412922382355,0.3412894606590271,0.47313639521598816,neutral,-0.15571533143520355
97,2018-08-13 07:17:00,"Heart disease is one of the leading causes of death in the U.S. Abiomed estimates that about 221,000 U.S. patients annually would benefit from procedures using Impella.",0.1402495950460434,0.19019758701324463,0.6695528626441956,neutral,-0.04994799196720123
98,2018-08-13 07:17:00,Plus the stock doesn't just have a U.S. focus.,0.02312447875738144,0.013531357981264591,0.963344156742096,neutral,0.009593120776116848
99,2018-08-13 07:17:00,"It also operates in Europe and Japan, and now India.",0.03349846228957176,0.005003292113542557,0.9614982604980469,neutral,0.028495170176029205
100,2018-08-13 07:17:00,"On July 26, Abiomed announced that Impella received approval from India's regulatory body.",0.7100782990455627,0.01039064209908247,0.2795310914516449,positive,0.699687659740448
101,2018-08-13 07:17:00,The first patient has now been treated with the pump in New Delhi.,0.12603753805160522,0.08529461920261383,0.7886678576469421,neutral,0.040742918848991394
102,2018-08-13 07:17:00,"""Abiomed is committed to expanding access to our heart recovery products around the world.",0.8987483382225037,0.012014057487249374,0.08923756331205368,positive,0.8867343068122864
103,2018-08-13 07:17:00,"We are moving forward to establish Heart Recovery Programs in India, starting with limited centers of excellence in New Delhi and Jaipur,"" said Abiomed CEO Michael R. Minogue.",0.8121539354324341,0.011673364788293839,0.17617274820804596,positive,0.8004805445671082
104,2018-08-13 07:17:00,"Overall, Abiomed has received five buy ratings from the Street vs just one hold rating.",0.8037711977958679,0.01772269420325756,0.17850610613822937,positive,0.7860485315322876
105,2018-08-13 07:17:00,This is over the last three months.,0.020616544410586357,0.010664016008377075,0.968719482421875,neutral,0.009952528402209282
106,2018-08-13 07:17:00,Their average price target works out at $454.,0.03181229531764984,0.02257373556494713,0.9456139802932739,neutral,0.009238559752702713
107,2018-08-13 07:17:00,See what other Top Analysts are saying about ABMD .,0.017935575917363167,0.008747107349336147,0.9733172655105591,neutral,0.00918846856802702
108,2018-08-13 07:17:00,"TipRanks.com offers exclusive insights for investors by focusing on the moves of experts: Analysts, Insiders, Bloggers, Hedge Fund Managers and more.",0.030375348404049873,0.006200163159519434,0.9634244441986084,neutral,0.024175185710191727
109,2018-08-13 07:17:00,See what the experts are saying about your stocks now at TipRanks.com .,0.026852857321500778,0.012680605985224247,0.9604665040969849,neutral,0.014172251336276531
110,2018-08-13 07:17:00,"As of this writing, Harriet Lefton did not hold a position in any of the aforementioned securities.",0.009872709400951862,0.022091234102845192,0.9680359959602356,neutral,-0.01221852470189333
111,2018-08-13 07:17:00,The post 7 Momentum Stocks That Will Power Through 2018 appeared first on InvestorPlace .,0.05037854611873627,0.013774100691080093,0.9358473420143127,neutral,0.036604445427656174
112,2018-08-13 07:17:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
